These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Iris cyst secondary to latanoprost mimicking iris melanoma. Browning DJ; Perkins SL; Lark KK Am J Ophthalmol; 2003 Mar; 135(3):419-21. PubMed ID: 12614778 [TBL] [Abstract][Full Text] [Related]
6. Iris pigment epithelial cyst induced by topical administration of latanoprost. Lai IC; Kuo MT; Teng LM Br J Ophthalmol; 2003 Mar; 87(3):366. PubMed ID: 12598462 [No Abstract] [Full Text] [Related]
7. The fine structure of an iridectomy specimen from a patient with latanoprost-induced eye color change. Grierson I; Lee WR; Albert DM Arch Ophthalmol; 1999 Mar; 117(3):394-6. PubMed ID: 10088822 [No Abstract] [Full Text] [Related]
8. Evidence of early change in iris color with latanoprost use. Pappas RM; Pusin S; Higginbotham EJ Arch Ophthalmol; 1998 Aug; 116(8):1115-6. PubMed ID: 9715697 [No Abstract] [Full Text] [Related]
9. Increased iris pigment in a child due to latanoprost. Brown SM Arch Ophthalmol; 1998 Dec; 116(12):1683-4. PubMed ID: 9869807 [No Abstract] [Full Text] [Related]
10. Histology and fine structure of the iris and outflow system following latanoprost therapy. Grierson I; Pfeiffer N; Cracknell KP; Appleton P Surv Ophthalmol; 2002 Aug; 47 Suppl 1():S176-84. PubMed ID: 12204715 [TBL] [Abstract][Full Text] [Related]
11. A 12-month, randomized, double-masked study comparing latanoprost with timolol in pigmentary glaucoma. Mastropasqua L; Carpineto P; Ciancaglini M; Gallenga PE Ophthalmology; 1999 Mar; 106(3):550-5. PubMed ID: 10080213 [TBL] [Abstract][Full Text] [Related]
13. Analysis of irises with a latanoprost-induced change in iris color. Arranz-Marquez E; Teus MA; Saornil MA; Mendez MC; Gil R Am J Ophthalmol; 2004 Oct; 138(4):625-30. PubMed ID: 15488791 [TBL] [Abstract][Full Text] [Related]
17. A study of histopathological features of latanoprost-treated irides with or without darkening compared with non-latanoprost-treated irides. Albert DM; Gangnon RE; Grossniklaus HE; Green WR; Darjatmoko S; Kulkarni AD Arch Ophthalmol; 2008 May; 126(5):626-31. PubMed ID: 18474771 [TBL] [Abstract][Full Text] [Related]
18. Iris-color change developed after topical isopropyl unoprostone treatment. Yamamoto T; Kitazawa Y J Glaucoma; 1997 Dec; 6(6):430-2. PubMed ID: 9407373 [TBL] [Abstract][Full Text] [Related]
19. Five-year, multicenter safety study of fixed-combination latanoprost/timolol (Xalacom) for open-angle glaucoma and ocular hypertension. Alm A; Grunden JW; Kwok KK J Glaucoma; 2011; 20(4):215-22. PubMed ID: 20520568 [TBL] [Abstract][Full Text] [Related]
20. A prospective study of iridial pigmentation and eyelash changes due to ophthalmic treatment with latanoprost. Chiba T; Kashiwagi K; Ishijima K; Furuichi M; Kogure S; Abe K; Chiba N; Tsukahara S Jpn J Ophthalmol; 2004; 48(2):141-7. PubMed ID: 15060793 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]